COVID-19

News

The unprecedented challenge of pricing a coronavirus vaccine

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

German vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost its manufacturing capacity for its potential COVID-19 vaccine.

News

Regeneron begins late-stage trial testing COVID-19 antibody ...

Regeneron has begun a late-stage clinical trial testing its double “antibody cocktail” as a preventive treatment for COVID-19.

News

Digital techniques could 'turbocharge' R&D after COVID-19, s...

The UK’s Royal Society of Chemistry has called for digital techniques to be more widely used as part of a new post-COVID national research strategy that could make scientific discovery happ

News

European Commission approves Gilead's remdesivir for COVID-1...

The European Commission has conditionally approved Gilead’s remdesivir for treatment of COVID-19, the first drug officially cleared for use against the disease by EU regulators.

Views & Analysis

AI chatbots step up to help fight COVID-19

The COVID-19 pandemic has placed enormous stress on both healthcare systems and researchers, and people all across the sector are looking for digital solutions to help ease the pressure.

News

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

GlaxoSmithKline and Sanofi are close to agreeing a £500m deal to supply the UK government with 60 million doses of their potential coroanvirus vaccine, according to a press report.

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

Regeneron begins late-stage trial testing COVID-19 antibody ...

Digital techniques could 'turbocharge' R&D after COVID-19, s...

European Commission approves Gilead's remdesivir for COVID-1...

AI chatbots step up to help fight COVID-19

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks